Annual Accounts Payable
$1.76 M
+$163.00 K+10.18%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual accounts payable is $1.76 million, with the most recent change of +$163.00 thousand (+10.18%) on December 31, 2022.
- During the last 3 years, EVLO annual accounts payable has risen by +$1.14 million (+184.52%).
- EVLO annual accounts payable is now at all-time high.
Performance
EVLO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$526.00 K
-$3.24 M-86.03%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly accounts payable is $526.00 thousand, with the most recent change of -$3.24 million (-86.03%) on September 30, 2023.
- Over the past year, EVLO quarterly accounts payable has dropped by -$1.02 million (-66.06%).
- EVLO quarterly accounts payable is now -86.03% below its all-time high of $3.77 million, reached on June 30, 2023.
Performance
EVLO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
EVLO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | -66.1% |
| 3 y3 years | +184.5% | -80.7% |
| 5 y5 years | +25.0% | -81.7% |
EVLO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.2% | -86.0% | at low |
| 5 y | 5-year | at high | +184.5% | -86.0% | +38.4% |
| alltime | all time | at high | +184.5% | -86.0% | +38.4% |
Evelo Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $526.00 K(-86.0%) |
| Jun 2023 | - | $3.77 M(+148.7%) |
| Mar 2023 | - | $1.51 M(-14.2%) |
| Dec 2022 | $1.76 M(+10.2%) | $1.76 M(+13.8%) |
| Sep 2022 | - | $1.55 M(-31.0%) |
| Jun 2022 | - | $2.25 M(+27.7%) |
| Mar 2022 | - | $1.76 M(+9.9%) |
| Dec 2021 | $1.60 M(+11.0%) | $1.60 M(-36.4%) |
| Sep 2021 | - | $2.52 M(+8.5%) |
| Jun 2021 | - | $2.32 M(+510.3%) |
| Mar 2021 | - | $380.00 K(-73.6%) |
| Dec 2020 | $1.44 M | $1.44 M(-47.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $2.73 M(-20.6%) |
| Jun 2020 | - | $3.44 M(+184.2%) |
| Mar 2020 | - | $1.21 M(+95.2%) |
| Dec 2019 | $620.00 K(-59.2%) | $620.00 K(-54.3%) |
| Sep 2019 | - | $1.36 M(-49.6%) |
| Jun 2019 | - | $2.69 M(+95.3%) |
| Mar 2019 | - | $1.38 M(-9.2%) |
| Dec 2018 | $1.52 M(+7.7%) | $1.52 M(-47.3%) |
| Sep 2018 | - | $2.88 M(+7.5%) |
| Jun 2018 | - | $2.68 M(+96.0%) |
| Mar 2018 | - | $1.37 M(-3.1%) |
| Dec 2017 | $1.41 M(+121.5%) | $1.41 M |
| Dec 2016 | $637.00 K | - |
FAQ
- What is Evelo Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Evelo Biosciences?
- What is Evelo Biosciences annual accounts payable year-on-year change?
- What is Evelo Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Evelo Biosciences?
- What is Evelo Biosciences quarterly accounts payable year-on-year change?
What is Evelo Biosciences annual accounts payable?
The current annual accounts payable of EVLO is $1.76 M
What is the all time high annual accounts payable for Evelo Biosciences?
Evelo Biosciences all-time high annual accounts payable is $1.76 M
What is Evelo Biosciences annual accounts payable year-on-year change?
Over the past year, EVLO annual accounts payable has changed by +$163.00 K (+10.18%)
What is Evelo Biosciences quarterly accounts payable?
The current quarterly accounts payable of EVLO is $526.00 K
What is the all time high quarterly accounts payable for Evelo Biosciences?
Evelo Biosciences all-time high quarterly accounts payable is $3.77 M
What is Evelo Biosciences quarterly accounts payable year-on-year change?
Over the past year, EVLO quarterly accounts payable has changed by -$1.02 M (-66.06%)